Definitive Healthcare Corp. (NASDAQ:DH - Get Free Report) has been assigned an average recommendation of "Hold" from the six brokerages that are currently covering the stock, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and one has assigned a buy rating to the company. The average 12 month price target among brokers that have updated their coverage on the stock in the last year is $4.7333.
DH has been the topic of several research analyst reports. Wall Street Zen raised shares of Definitive Healthcare from a "hold" rating to a "buy" rating in a research report on Saturday, June 21st. The Goldman Sachs Group raised their target price on shares of Definitive Healthcare from $3.00 to $3.40 and gave the stock a "neutral" rating in a research report on Monday, May 12th. BTIG Research cut shares of Definitive Healthcare from a "buy" rating to a "neutral" rating in a research report on Friday, May 9th. Robert W. Baird set a $4.00 price target on shares of Definitive Healthcare in a research report on Friday, August 8th. Finally, Stifel Nicolaus lifted their price target on shares of Definitive Healthcare from $5.00 to $6.00 and gave the company a "buy" rating in a research report on Friday, August 8th.
Get Our Latest Analysis on DH
Hedge Funds Weigh In On Definitive Healthcare
Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Arrowstreet Capital Limited Partnership acquired a new position in shares of Definitive Healthcare during the 2nd quarter worth approximately $4,247,000. New York State Common Retirement Fund raised its holdings in Definitive Healthcare by 0.4% in the 2nd quarter. New York State Common Retirement Fund now owns 766,433 shares of the company's stock valued at $2,989,000 after acquiring an additional 3,066 shares in the last quarter. Heron Bay Capital Management raised its holdings in Definitive Healthcare by 43.0% in the 2nd quarter. Heron Bay Capital Management now owns 28,651 shares of the company's stock valued at $112,000 after acquiring an additional 8,615 shares in the last quarter. Creative Planning raised its holdings in shares of Definitive Healthcare by 41.7% during the 2nd quarter. Creative Planning now owns 28,628 shares of the company's stock worth $112,000 after buying an additional 8,428 shares in the last quarter. Finally, Connor Clark & Lunn Investment Management Ltd. raised its holdings in shares of Definitive Healthcare by 44.3% during the 2nd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 361,046 shares of the company's stock worth $1,408,000 after buying an additional 110,894 shares in the last quarter. Institutional investors own 98.67% of the company's stock.
Definitive Healthcare Price Performance
Shares of DH traded up $0.35 during trading hours on Monday, reaching $3.95. The company had a trading volume of 500,924 shares, compared to its average volume of 841,157. The firm has a 50 day simple moving average of $3.90 and a 200-day simple moving average of $3.60. The company has a current ratio of 1.65, a quick ratio of 1.75 and a debt-to-equity ratio of 0.39. The company has a market capitalization of $586.38 million, a price-to-earnings ratio of -1.48, a PEG ratio of 5.92 and a beta of 1.64. Definitive Healthcare has a 12-month low of $2.15 and a 12-month high of $5.68.
Definitive Healthcare Company Profile
(
Get Free Report)
Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.
Featured Stories

Before you consider Definitive Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Definitive Healthcare wasn't on the list.
While Definitive Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.